Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
TMP920 is an antagonist of retinoic acid receptor-related orphan receptor γt (RORγt; IC50 = 30 nM).1 It selectively inhibits RORγt-dependent transactivation over transactivation of 22 other nuclear receptors in HEK293 cells at 10 µM. TMP920 reduces the differentiation of primary naïve CD4+ T cells into T helper 17 (Th17) cells and reduces the levels of IL-17 in wild-type but not RORγt-deficient CD4+ T cells isolated from mice in a model of experimental autoimmune encephalomyelitis (EAE). It reduces CNS-infiltrating mononuclear cells, disease severity, and disease progression in a mouse model of EAE at 500 µg/animal.
WARNING This product is not for human or veterinary use.
1. Small-